Augmedix Announces Participation in Upcoming Investor Conferences in September 2023
18 August 2023 - 1:00PM
Augmedix (Nasdaq: AUGX), a healthcare technology company that
delivers industry-leading ambient medical documentation and data
solutions to healthcare systems, physician practices, hospitals,
and telemedicine practitioners, today announced that it will
participate in the following investor conferences during September
2023.
- Wells
Fargo Healthcare Conference, September 6-8, 2023, Boston:
Manny Krakaris, Chief Executive Officer, and Paul Ginocchio, Chief
Financial Officer, will host one-on-one investor meetings during
the conference.
- Lake
Street Best Ideas Growth Conference, September 14, 2023, New
York: Mr. Krakaris and Mr. Ginocchio will host one-on-one
investor meetings during the conference.
- Cantor
Fitzgerald Global Healthcare Conference, September 26-28, 2023, New
York: Mr. Krakaris and Mr. Ginocchio will participate in a
fireside chat on Thursday, September 28th at 2:25 pm ET. The
webcast link can be found at https://ir.augmedix.com/news-events
and available closer to the conference. Management will also host
one-on-one investor meetings.
Attending investors interested in meeting with
Augmedix management during these conferences can contact the IR
team at investors@augmedix.com. Investors interested in learning
more about these events can also contact their Wells Fargo, Lake
Street, or Cantor Fitzgerald representative.
About Augmedix
Augmedix (Nasdaq: AUGX) delivers
industry-leading, ambient medical documentation and data solutions
to healthcare systems, physician practices, hospitals, and
telemedicine practitioners. Augmedix is on a mission to help
clinicians and patients form a human connection at the point of
care with unobtrusive technology. Augmedix’s proprietary
Notebuilder Platform extracts relevant data from natural
clinician-patient conversations and converts that data into medical
notes in real time, which are seamlessly transferred to the EHR.
The company’s platform uses automatic speech recognition, natural
language processing, including large language models, and medical
documentation specialists to generate accurate and timely medical
notes. Leveraging this platform, Augmedix’s products relieve
clinicians of administrative burden, in turn, reducing burnout and
increasing both clinician and patient satisfaction. Augmedix is
also leading the revolution in transforming point-of-care
information into valuable structured data that can drive lower
revenue cycle management costs, higher reimbursement levels and
deliver important clinical feedback to the point of care. Augmedix
is headquartered in San Francisco, CA, with offices around the
world. To learn more, visit www.augmedix.com.
Contact Information
Investors:Matt Chesler, CFAFNK IR(646)
809-2183augx@fnkir.cominvestors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024